Yahoo Finance • 16 days ago
If you go to California's Redwood National Park, you can see the world's tallest tree -- a redwood called Hyperion that's over 380 feet tall. Like every other tree, though, Hyperion started as a small seed. Stocks can be like this, beginn... Full story
Yahoo Finance • a month ago
It's been a tough past three years for biotech stocks. Although the COVID-19 pandemic sparked bullish interest in the industry, this interest has waned since the contagion began winding down. Between late 2021 and now, the Nasdaq Biotechno... Full story
Yahoo Finance • a month ago
Ozempic and Wegovy are the rock stars of the biopharmaceutical world. When celebrities talk about a prescription drug, it has reached the big time. And that's what has happened with Novo Nordisk's two blockbusters. The success of Ozempic... Full story
Yahoo Finance • 2 months ago
Does a 100% return in less than seven years sound pretty good? Most investors would probably say so. But which stocks are good candidates to achieve such a gain? Three Motley Fool contributors think they've found magnificent stocks that c... Full story
Yahoo Finance • 2 months ago
What's the most important ingredient for investing successfully? Time. However, some stocks require much less time to deliver huge returns than others. You may have to be patient for significant returns if you invest in stocks that are ab... Full story
Yahoo Finance • 3 months ago
Two companies stand at the center of the obesity drug market right now. Novo Nordisk continues to rake in money from its weight-loss drug Wegovy (and from off-label usage of its type 2 diabetes drug Ozempic.) Eli Lilly is hot on Novo Nordi... Full story
Yahoo Finance • 3 months ago
With Viking Therapeutics (NASDAQ: VKTX) stock exploding skyward by 528% over the last 12 months, it's easy to wonder if the opportunity to buy its stock is too good to be true -- and a bit too late. But in this case, there's actually a we... Full story
Yahoo Finance • 3 months ago
Shares of Viking Therapeutics(NASDAQ: VKTX) were plunging 17.4% lower as of 11:52 a.m. ET on Thursday. This decline wasn't caused by an announcement by Viking. Instead, the sell-off appears to be related to Novo Nordisk(NYSE: NVO) reportin... Full story
Yahoo Finance • 3 months ago
Comparing Eli Lilly(NYSE: LLY) and Viking Therapeutics(NASDAQ: VKTX) might initially seem odd. The two drugmakers don't seem to have much in common. Eli Lilly is more than 50 times the size of Viking by market cap and boasts a long list of... Full story
Yahoo Finance • 3 months ago
After rising by 137% in one day upon the publication of favorable phase 2 clinical trial results on Feb. 27, Viking Therapeutics (NASDAQ: VKTX) is now doubtlessly on many investors' radars. Soon enough, the biotech will likely try to launc... Full story
Yahoo Finance • 7 months ago
Raising 2023 Guidance Investor and Analyst Day to be held on Tuesday December 12th in New York City Conference call begins at 4:30 p.m. Eastern Time today SAN DIEGO, November 08, 2023--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporate... Full story
Yahoo Finance • a year ago
Shares of the clinical-stage metabolic disorder specialist Viking Therapeutics (NASDAQ: VKTX) were down by 6.45% on moderate volume as of 1:42 p.m. ET Thursday afternoon. Small- and mid-cap biotech stocks are under pressure today following... Full story
Yahoo Finance • a year ago
Viking unveiled promising test results Tuesday for a liver disease drug, and VKTX stock hit a record high after initially yo-yoing. Continue reading... Full story
Yahoo Finance • a year ago
The biotech's shares rose briefly this morning following a sizable price target revision by an investing firm. Continue reading... Full story
Yahoo Finance • a year ago
The WHO will consider adding obesity treatments to its "essential medicines list." The move could help shares of Eli Lilly and Novo Nordisk. Continue reading... Full story
Yahoo Finance • a year ago
Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Range of VK2809 Doses for up to 52 Weeks; Data for Primary Endpoint Expected in First Half of 2023 SAN DIEGO, Jan. 9, 2023 /PRNewswire/ -- Viking Therapeutics, Inc... Full story
Yahoo Finance • 2 years ago
SAN DIEGO, Nov. 8, 2022 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced th... Full story
Yahoo Finance • 2 years ago
Conference Call Scheduled for Wednesday, October 26 at 4:30 p.m. Eastern Time SAN DIEGO, Oct. 18, 2022 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the developm... Full story
Yahoo Finance • 2 years ago
Every investor in Viking Therapeutics, Inc. (NASDAQ:VKTX) should be aware of the most powerful shareholder groups. Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. C... Full story
Yahoo Finance • 2 years ago
Study Enrollment and Dosing to Resume SAN DIEGO, July 19, 2022 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and e... Full story
Home
Money Search
Trending Sports
Gallery
Shop
Blog
Examples
Data & Glossary
Elements of Bball
Harden Maze
About
